Dogwood Therapeutics, Inc. (DWTX)
DWTX Stock Price Chart
Explore Dogwood Therapeutics, Inc. interactive price chart. Choose custom timeframes to analyze DWTX price movements and trends.
DWTX Company Profile
Discover essential business fundamentals and corporate details for Dogwood Therapeutics, Inc. (DWTX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
—
Employees
12.00
Website
https://www.dwtx.comCEO
Gregory Duncan
Description
Dogwood Therapeutics, Inc., a development-stage biotechnology company, focuses on developing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It also develops IMC-2, a combination of valacyclovir and celecoxib for the treatment of managing the fatigue, sleep, attention, pain, autonomic function, and anxiety associated with long COVID. The company was formerly known as Virios Therapeutics, Inc. and changed its name to Dogwood Therapeutics, Inc. in October 2024. The company was founded in 2012 and is headquartered in Alpharetta, Georgia.
DWTX Financial Timeline
Browse a chronological timeline of Dogwood Therapeutics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 May 2026
Upcoming earnings on 6 Nov 2025
EPS estimate is -$1.24.
Earnings released on 13 Aug 2025
EPS came in at -$1.99 falling short of the estimated -$1.26 by -57.94%.
Earnings released on 8 May 2025
EPS came in at -$4.21 falling short of the estimated -$0.77 by -446.75%.
Earnings released on 26 Feb 2025
EPS came in at -$5.90 falling short of the estimated -$1.36 by -333.60%.
Earnings released on 7 Nov 2024
EPS came in at -$2.05 falling short of the estimated -$1.33 by -54.14%.
Earnings released on 8 Aug 2024
EPS came in at -$0.05 surpassing the estimated -$0.07 by +28.57%.
Earnings released on 9 May 2024
EPS came in at -$0.07 surpassing the estimated -$0.08 by +12.50%.
Earnings released on 31 Dec 2023
EPS came in at -$1.43 surpassing the estimated -$1.75 by +18.17%.
Earnings released on 30 Sept 2023
EPS came in at -$1.62 surpassing the estimated -$2.25 by +28.13%.
Earnings released on 30 Jun 2023
EPS came in at -$1.96 falling short of the estimated -$1.25 by -56.52%.
Earnings released on 31 Mar 2023
EPS came in at -$2.07 surpassing the estimated -$4.00 by +48.28%.
Earnings released on 31 Dec 2022
EPS came in at -$2.79 .
Earnings released on 30 Sept 2022
EPS came in at -$7.00 surpassing the estimated -$11.50 by +39.14%.
Earnings released on 30 Jun 2022
EPS came in at -$11.01 .
Earnings released on 31 Mar 2022
EPS came in at -$11.89 .
Earnings released on 31 Dec 2021
EPS came in at -$13.54 .
Earnings released on 30 Sept 2021
EPS came in at -$12.33 .
Earnings released on 30 Jun 2021
EPS came in at -$12.85 .
Earnings released on 31 Mar 2021
EPS came in at -$9.18 .
Earnings released on 31 Dec 2020
EPS came in at -$31.18 .
Earnings released on 30 Sept 2020
EPS came in at -$13.96 .
DWTX Stock Performance
Access detailed DWTX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.